Abbott Laboratories Statistics
Total Valuation
LON:0Q15 has a market cap or net worth of GBP 167.89 billion. The enterprise value is 173.56 billion.
Market Cap | 167.89B |
Enterprise Value | 173.56B |
Important Dates
The last earnings date was Wednesday, April 16, 2025.
Earnings Date | Apr 16, 2025 |
Ex-Dividend Date | Apr 15, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.07% |
Shares Change (QoQ) | +0.06% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.72B |
Valuation Ratios
The trailing PE ratio is 16.13.
PE Ratio | 16.13 |
Forward PE | n/a |
PS Ratio | 5.12 |
PB Ratio | 4.53 |
P/TBV Ratio | 12.11 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 16.67 |
EV / Sales | 5.46 |
EV / EBITDA | 20.32 |
EV / EBIT | 29.67 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.32 |
Debt / EBITDA | 1.34 |
Debt / FCF | n/a |
Interest Coverage | 14.23 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 8.32% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 287,490 |
Profits Per Employee | 91,324 |
Employee Count | 114,000 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.16% in the last 52 weeks. The beta is 0.66, so LON:0Q15's price volatility has been lower than the market average.
Beta (5Y) | 0.66 |
52-Week Price Change | +20.16% |
50-Day Moving Average | 130.70 |
200-Day Moving Average | 118.55 |
Relative Strength Index (RSI) | 48.85 |
Average Volume (20 Days) | 5,457 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.99 |
Income Statement
In the last 12 months, LON:0Q15 had revenue of GBP 32.77 billion and earned 10.41 billion in profits. Earnings per share was 5.96.
Revenue | 32.77B |
Gross Profit | 18.33B |
Operating Income | 6.03B |
Pretax Income | 5.69B |
Net Income | 10.41B |
EBITDA | 8.52B |
EBIT | 6.03B |
Earnings Per Share (EPS) | 5.96 |
Balance Sheet
The company has 6.17 billion in cash and 11.82 billion in debt, giving a net cash position of -5.66 billion.
Cash & Cash Equivalents | 6.17B |
Total Debt | 11.82B |
Net Cash | -5.66B |
Net Cash Per Share | n/a |
Equity (Book Value) | 37.07B |
Book Value Per Share | 21.30 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 55.92%, with operating and profit margins of 18.39% and 31.89%.
Gross Margin | 55.92% |
Operating Margin | 18.39% |
Pretax Margin | 17.37% |
Profit Margin | 31.89% |
EBITDA Margin | 25.98% |
EBIT Margin | 18.39% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.77, which amounts to a dividend yield of 1.38%.
Dividend Per Share | 1.77 |
Dividend Yield | 1.38% |
Dividend Growth (YoY) | 5.35% |
Years of Dividend Growth | 6 |
Payout Ratio | n/a |
Buyback Yield | 0.07% |
Shareholder Yield | 1.45% |
Earnings Yield | 6.20% |
FCF Yield | n/a |
Stock Splits
The last stock split was on June 1, 1998. It was a forward split with a ratio of 2.
Last Split Date | Jun 1, 1998 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |